Celldex Therapeutics Jumps 25% Amid Brain Cancer Study By: Benzinga via Benzinga November 17, 2014 at 10:47 AM EST Celldex Therapeutics, Inc. (NASDAQ: CLDX) gained sharply Monday on news released late last week a small trial of its brain cancer ... Read More >> Related Stocks: Celldex Therapeutics